Renal Care Group to Hold Special Meeting August 24, 2005
Posted on: Thursday, 21 July 2005, 18:00 CDT
Renal Care Group, Inc. (NYSE: RCI) announced today that it will have a Special Meeting of Shareholders on Wednesday, August 24, 2005. The Special Meeting will be held at 9:00 a.m. CDT at the Nashville Marriott at Vanderbilt University in Nashville, Tennessee. At the Special Meeting, shareholders of record as of July 1, 2005, will vote on a proposal to adopt the agreement dated May 3, 2005 under which Fresenius Medical Care AG will acquire Renal Care Group, Inc. for $48.00 per common share.
Renal Care Group, Inc. is a specialized dialysis services company that provides care to patients with kidney disease. The Company serves over 31,000 patients at more than 445 outpatient dialysis facilities in addition to providing acute dialysis services at more than 210 hospitals. Over 9,100 associates provide services across the Company's 34-state network. More information about Renal Care Group, Inc. may be found at www.renalcaregroup.com.
Certain statements in this press release, particularly statements about the acquisition of Renal Care Group by Fresenius Medical Care, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are usually preceded by words like believe, expect, plan, intend, will and the like, include statements regarding the transaction with Fresenius Medical Care and any other statements that necessarily depend on future events. These forward-looking statements reflect management's expectations and are based upon currently available information. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Renal Care Group to differ materially from those expressed in or implied by the forward-looking statements, including risks related to: the consummation of the transaction between Renal Care Group and Fresenius Medical Care, the dependence of our profits on the services we provide to a small portion of our patients with private insurance; changes in the Medicare and Medicaid programs; changes in the health care delivery, financing or reimbursement systems; risks related to the drug Epogen (EPO); compliance with health care and other applicable laws; and dependence on executive officers. These and other factors affecting the Company are discussed in more detail in Renal Care Group's reports filed with the Securities and Exchange Commission, including without limitation Renal Care Group's most recent annual report on Form 10-K and any quarterly reports on Form 10-Q filed after that annual report. Copies of these filings are available from Renal Care Group upon request.
Source: Business Wire
Related Articles
- Fresenius Medical Care Announces 2007 Disaster Preparedness Plan to Ensure Vital Dialysis Care During Hurricanes
- Fresenius Medical Care to Offer Nephrology Electronic Health Record System for Chronic Kidney Disease
- Fresenius Medical Care Announces 2006 Disaster Preparedness Plan to Ensure Vital Dialysis Care for Patients During Hurricanes
- Fresenius Medical Care Extracorporeal Alliance Awarded Joint Commission Certification
- Renal Care Group Signs Agreement to Sell Required Facilities in Connection With Fresenius Medical Care Transaction
- Fresenius Medical Care North America Purchases the Remaining Shares of Renaissance Health Care, Inc., And Optimal Renal Care, LLC, and Merges the Two Companies
- An Endless Wait for Health Care: Poor, Uninsured Face Long Line for Medical Services
- Fresenius Medical Care North America Awarded ESRD Demonstration Project By CMS
- Fresenius Medical Care Supports Hurricane Katrina Relief Efforts
- Gary Brukardt and Key Renal Care Group Executives to Join Fresenius Medical Care Upon Closing of the Acquisition
 |
 |
User Comments (0)
RSS Feeds